James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Despite the Stumble, OREX Stock & Contrave Are Still Compelling

OREX stock owners winced on Tuesday after the FDA pulled the rug out from underneath Contrave, but patience will pay off.

Straggling Bulls May Trample Those Who Jump the Gun

The Russell 2000 and the S&P 500 both have some key technical floors they need to hit before we can come to any longer-term conclusions.

OK, It’s Time for the Uncomfortable S&P 2000 Chat

S&P 2000 mania only highlights all the things that can -- and probably will -- torpedo the S&P 500 here.

Where to Invest When Coffee Prices Go North

Coffee prices are headed higher, but before jumping to bearish conclusions about coffee stocks like Kraft Foods or J.M. Smucker, read this.

3 Dividend Stocks You Can Easily Upgrade

Phillip Morris, AT&T, and Merck are well-loved dividend stocks, but they aren't the top ways to generate income in their respective industries.